title: Seminal vesicle abscess following prostate biopsy requiring transgluteal percutaneous drainage.
abstract: Transrectal ultrasound guided biopsy (TRUSB) of the prostate directly contaminates the prostate with rectal flora. Patients commonly receive fluoroquinolone (FQ) antibiotics to prevent infection. Infectious complications following TRUSB are increasing. The most common offending organism is Escherichia coli (E. coli), with isolates of this bacteria showing growing resistance to FQs. We present to our knowledge the first reported case of seminal vesicle abscess formation after TRUSB. The abscess was initially not seen on computed tomography and eventually treated with percutaneous drainage by a transgluteal approach. We review literature on infectious complications following TRUSB with implications for future antibiotic prophylaxis.
authors.affiliation: Department of Urology, The George Washington University Hospital, Washington, DC 20037, USA.
authors.forename: Christopher E
authors.initials: CE
authors.lastname: Bayne
authors.forename: William A
authors.initials: WA
authors.lastname: Davis
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Rothstein
authors.forename: Jason D
authors.initials: JD
authors.lastname: Engel
mesh_terms: D000038:Abscess / Q000209:etiology* / Q000628:therapy; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002081:Buttocks; D002443:Ceftriaxone / Q000627:therapeutic use; D004322:Drainage / Q000379:methods*; D004926:Escherichia coli / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000209:etiology* / Q000628:therapy; D006801:Humans; D061705:Image-Guided Biopsy / Q000009:adverse effects*; D064704:Levofloxacin / Q000627:therapeutic use; D008297:Male; D009582:Nitrofurantoin / Q000627:therapeutic use; D011467:Prostate / Q000473:pathology*; D012669:Seminal Vesicles / Q000382:microbiology*; D016896:Treatment Outcome; D036761:Ultrasound, High-Intensity Focused, Transrectal / Q000009:adverse effects*
chemical_list: D000900:Anti-Bacterial Agents; D064704:Levofloxacin; D002443:Ceftriaxone; D009582:Nitrofurantoin